Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-24 @ 10:44 PM
Ignite Modification Date: 2025-12-25 @ 8:15 PM
NCT ID: NCT02534935
Term: Rhinovirus infection
Organ System: Infections and infestations
Assessment Type: NON_SYSTEMATIC_ASSESSMENT
Source Vocabulary: None
Notes: MedDRA v20.0 for Group 1: 60mcg bivalent rLP2086 (\>=12 months to \<24 months), Group 2: 120mcg bivalent rLP2086 (\>=12 months to \<24 months), Group 3: HAV/Saline (\>=12 months to \<24 months); MedDRA v23.0 for booster stage and safety follow up groups.
Study: NCT02534935
Study Brief: Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers.
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 None 0 44 View
EG001 None 0 220 View
EG002 None 0 132 View
EG003 None 1 147 View
EG004 None 0 44 View
EG005 None 0 220 View
EG006 None 0 132 View